Jun 5, 2013, 13:00 by Michael Croft

Outsourcing Pharma | Adaptive trials continue to gain ground, says Ken Getz, Director of the Tufts Center for the Study of Drug Development. He says the industry as a whole is seeing an adoption rate of about 20%, with regulators receptive to even broader implementation.

Jun 5, 2013, 12:00 by Michael Croft

Clinical Inforamtics News | Guest Commentary | The life sciences industry has been focused on improving clinical trial productivity in recent years, realizing significant data management efficiency gains over the last decade largely due to the widespread adoption of remote data capture technologies. However, we still have substantial opportunities to further reduce the cost and improve the speed and quality of data collected during clinical trials. The rapid emergence of machine-to-machine (M2M) technologies can transform how we collect clinical trial data and dramatically improve its accuracy and immediacy.

Jun 4, 2013, 13:00 by Michael Croft

Clinical Informatics News Brief | The Robert Wood Johnson Foundation has launched an app competition aimed at improving consumer understanding and use of data that compare hospital prices.

May 31, 2013, 13:00 by Michael Croft

Clinical Informatics News Brief | The European Parliament's public health committee released new rules for clinical trials yesterday. The rules are meant to make trials quicker and more transparent and help to provide better treatment.

May 30, 2013, 12:00 by Michael Croft

Computerworld | Predictive analytics is on the rise, and though it's still challenging to actually make future predictions. Medalogix examines patient records and makes predictions about hospital readmits.

May 29, 2013, 14:00 by Michael Croft

Labmate | Improving Voluntary Harmonization Procedures (VHPs) for multinational clinical trials applications expedites the creation and distribution of patient therapies.

May 29, 2013, 14:00 by Michael Croft

PharmaTimes | According to a study done by Tufts Center for the Study of Drug Development (CSDD), roughly 20% of ongoing clinical trials are currently using adaptive designs, and usage of these methods are expected to increase in the exploratory phase of drug development.

May 28, 2013, 07:00 by Michael Croft

Clinical Informatics News | When doctors like Marc Williams need to analyze thousands of variants in a patient’s genome to make a diagnosis, a little help can go a long way. Williams, the director of the Genomic Medicine Institute, won a Bio-IT World Best Practices award in Informatics at the Bio-IT World Conference & Expo this past month for his project testing the effectiveness of SimulConsult’s “Genome-Phenome Analyzer,” a tool to help clinicians analyze a patient’s genome. 

May 21, 2013, 11:00 by Michael Croft

Business Insider | CRO firm ClinTec International has opened an office in Istanbul. Now operating in 40 countries, ClinTec's Turkey office will further consolidate its presence in the Middle East and North Africa.

May 20, 2013, 11:00 by Michael Croft

PhysBizTech | Using a trial search engine and educational web videos, researchers at the Seidman Cancer Center at Case Western Reserve University School of Medicine have been looking into ways to help build enthusiasm for clinical trials from both patients and practitioners.

May 20, 2013, 11:00 by Michael Croft

MedicalXpress | Singapore's A*STAR and Swiss group Cytos Biotechnology have launched a Phase 1 clinical trial for an H1N1 flu vaccine, making use of Cytos’ virus-like particle (VLP) technology.

May 20, 2013, 07:00 by Michael Croft

Clinical Informatics News | Dr. Richard Gliklich, President of the Quintiles Outcome Division of Quintiles, gave Clinical Informatics News a summary of conversations and issues raised at the 2013 Post-Approval Summit.

May 16, 2013, 12:00 by Michael Croft

Diabetes News | Massachusetts Institute of Technology (MIT) researchers recently developed injectable nanoparticles for patients with type 1 diabetes. These nanoparticles are designed to replace the function of islet cells.

May 15, 2013, 11:00 by Michael Croft

CNN Money | Excellent reporting into the long-term criminal fraud at Ranbaxy—the Indian drug company that makes generic Lipitor.

May 15, 2013, 09:00 by Michael Croft

eCliniqua News Brief | Instem has acquired Logos Technologies, representing its strategic move into the early phase clinical trials market. Logos’ ALPHADAS software solution suite is a proactive eSource clinical trials system that is mobile, schedule-driven, and provides real-time bedside or station based direct data capture.

May 15, 2013, 08:00 by Michael Croft

eCliniqua | Certara and Veristat have formed an alliance to offer pharmacokinetic (PK) analysis, PK /pharmacodynamic (PD) modeling, population PK modeling, trial simulation, clinical biostatistics, medical writing, data management, clinical monitoring, safety management, and project management to their clients.

May 14, 2013, 13:00 by Michael Croft

Forbes | Using DNA hybridization and detection with a miniaturized nuclear magnetic resonance (NMR) device about the size of a microscope slide, researchers are able to test for several bacterial pathogens at once within hours.

May 14, 2013, 13:00 by Michael Croft

OncLive | The I-SPY trials for breast cancer are aiming to test several experimental therapies at once to determine which ones work best in which patients.

May 13, 2013, 11:00 by Michael Croft

News Medical | According to researchers at Total Care Cancer (a comprehensive approach to cancer launched at Moffitt Cancer Center), using biosamples for phase II cancer trials improves research efficiency, cost, and the rate of drug development.

May 10, 2013, 15:00 by Michael Croft

PBR | OnQ Research, a South Africa-based Clinical Research Organization, has selected Merge's eClinical OS solution for electronic data capture to expand their in-house data management service offering.